NVCR

NovoCure
NVCR

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.96B
EV
$1.72B
Shares Outstanding
111.49M
Beta
0.75

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$32.57
P/E 2025E
-
P/Revenue 2025E
3.12x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About NovoCure Limited

gainify
NVCR

NovoCure Limited

NVCR

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The com...

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Danziger, Asaf

Employees

1,488

IPO Date

2015-10-01

Headquarters

No. 4 The Forum, Second Floor, Grenville Street, Saint Helier JE2 4UF, Jersey

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.